The limited effectiveness of glucocorticosteroids (GC) in the management of COPD may be explained by the fact that GC have an effect on cytokine transcription but not posttranslational steps like IL-1β maturation [40]. The gene discussed is IL1B; the disease is chronic obstructive pulmonary disease.